Control IQ - FDA Approval target?

[Mila]

NEWS!

BREAKING NEWS from Tandem Diabetes

FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system For Immediate Release: December 13, 2019 The U.S. Food and Drug Administration today authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an interoperable automated glycemic controller device that automatically adjusts insulin delivery to a person with diabetes by connecting to an alternate…